Literature DB >> 7797909

Inflammatory cytokines produced in response to experimental human gonorrhea.

K H Ramsey1, H Schneider, A S Cross, J W Boslego, D L Hoover, T L Staley, R A Kuschner, C D Deal.   

Abstract

Inflammatory cytokine production in men was examined after intraurethral challenge of volunteers with Neisseria gonorrhoeae MS11mkA or MS11mkC. Increased interleukin (IL)-8, IL-6, and tumor necrosis factor-alpha (TNF-alpha) were detected in urine before the onset of symptoms and peaked simultaneously with the detection of IL-1 beta at the onset of symptoms. Urine cytokine levels returned to baseline or near baseline within 48 h after antibiotic therapy. In plasma, IL-8, TNF-alpha, IL-1 beta, and IL-6 were elevated at the onset of symptoms in 9, 5, 4, and 3 of 10 subjects, respectively, and returned to near normal within 48 h after treatment. IL-1 alpha and granulocyte-macrophage colony-stimulating factor were not consistently detected in urine or plasma after challenge. Cytokine mRNA transcripts in peripheral blood mononuclear cells were not altered by the infection. The findings suggest that IL-8, IL-6, and possibly TNF-alpha were produced at the local site of infection, whereas IL-1 beta was derived from infiltrating leukocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797909     DOI: 10.1093/infdis/172.1.186

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  58 in total

Review 1.  A bacterial siren song: intimate interactions between Neisseria and neutrophils.

Authors:  Alison K Criss; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2012-01-31       Impact factor: 60.633

2.  Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways.

Authors:  Mingfeng Liu; Constance M John; Gary A Jarvis
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 3.  Gonococcal Defenses against Antimicrobial Activities of Neutrophils.

Authors:  Allison Palmer; Alison K Criss
Journal:  Trends Microbiol       Date:  2018-08-13       Impact factor: 17.079

Review 4.  Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects.

Authors:  Gary A Jarvis; Theresa L Chang
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

5.  TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells.

Authors:  D N Quan; M D Cooper; J L Potter; M H Roberts; H Cheng; G A Jarvis
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313

Review 6.  The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women.

Authors:  Jennifer L Edwards; Michael A Apicella
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes.

Authors:  Alison K Criss; Ben Z Katz; H Steven Seifert
Journal:  Cell Microbiol       Date:  2009-03-12       Impact factor: 3.715

8.  Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses.

Authors:  Mathanraj Packiam; Sandra J Veit; Deborah J Anderson; Robin R Ingalls; Ann E Jerse
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

9.  Immortalization of human urethral epithelial cells: a model for the study of the pathogenesis of and the inflammatory cytokine response to Neisseria gonorrhoeae infection.

Authors:  Hillery A Harvey; Deborah M B Post; Michael A Apicella
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection.

Authors:  B Feinen; A E Jerse; S L Gaffen; M W Russell
Journal:  Mucosal Immunol       Date:  2010-01-27       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.